Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.320
+0.030 (1.31%)
At close: Dec 23, 2025, 1:00 PM EST
2.350
+0.030 (1.29%)
After-hours: Dec 23, 2025, 7:41 PM EST
Veru Inc. Market Cap
Veru Inc. has a market cap or net worth of $37.24 million as of December 23, 2025. Its market cap has decreased by -64.37% in one year.
Market Cap
37.24M
Enterprise Value
37.83M
1-Year Change
-64.37%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since December 1, 1998, Veru Inc.'s market cap has increased from $15.60M to $37.24M, an increase of 138.70%. That is a compound annual growth rate of 3.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 37.20M | -60.92% |
| Dec 31, 2024 | 95.20M | 41.25% |
| Dec 29, 2023 | 67.40M | -84.17% |
| Dec 30, 2022 | 425.70M | -9.69% |
| Dec 31, 2021 | 471.40M | -22.24% |
| Dec 31, 2020 | 606.20M | 178.20% |
| Dec 31, 2019 | 217.90M | 148.46% |
| Dec 31, 2018 | 87.70M | 44.48% |
| Dec 29, 2017 | 60.70M | 112.98% |
| Dec 30, 2016 | 28.50M | -32.30% |
| Dec 31, 2015 | 42.10M | -62.74% |
| Dec 31, 2014 | 113.00M | -53.73% |
| Dec 31, 2013 | 244.20M | 18.60% |
| Dec 31, 2012 | 205.90M | 63.80% |
| Dec 30, 2011 | 125.70M | -19.63% |
| Dec 31, 2010 | 156.40M | 24.42% |
| Dec 31, 2009 | 125.70M | 30.39% |
| Dec 31, 2008 | 96.40M | 38.31% |
| Dec 31, 2007 | 69.70M | 85.87% |
| Dec 29, 2006 | 37.50M | -7.64% |
| Dec 30, 2005 | 40.60M | -11.74% |
| Dec 31, 2004 | 46.00M | -14.34% |
| Dec 31, 2003 | 53.70M | 88.42% |
| Dec 31, 2002 | 28.50M | 139.50% |
| Dec 31, 2001 | 11.90M | 80.30% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |